Core competence demonstrated across ENGIMA (magneto-piezoelectric nanostructures), MELON (memristive and multiferroic materials), and HUNTER (humidity-to-electricity conversion).
NANOTECHCENTER LLC
Ukrainian SME specializing in ferroelectric, multiferroic, and memristive nanomaterials for electronics, energy harvesting, and biomedical applications.
Their core work
NANOTECHCENTER is a Ukrainian private company specializing in advanced nanomaterials research, with deep expertise in ferroelectric, multiferroic, and piezoelectric nanostructures. They develop functional materials for applications ranging from energy harvesting (humidity-to-electricity conversion) to neuromorphic computing and safe-by-design nanomaterial manufacturing. More recently, they have expanded into bioactive nanomaterials for neurodegenerative disease prevention, bridging materials science with biomedical applications.
What they specialise in
SABYDOMA focused on safe-by-design nanomaterials with on-line production screening, while NANOGUARD2AR addressed indoor air safety via nanomaterial engineering.
MELON project targets memristors and resistive switching for emergent logic units in nanoelectronics — their largest funded project at EUR 294,400.
HUNTER and SSHARE both explore humidity-to-electricity conversion, with SSHARE advancing toward net-zero energy radiant adsorption systems.
PhytoAPP (2021-2026) investigates phytochemical-based nanomaterial inhibitors for Alzheimer's and Parkinson's disease prevention.
How they've shifted over time
NANOTECHCENTER's early work (2015-2019) centered on fundamental materials physics — piezoelectricity, magnetoelectric coupling, superlattices, and multicaloric nanostructures. From 2020 onward, the focus shifted decisively toward applied electronics (memristors, neuromorphic computing, resistive switching) and industrial nanomaterial processes (on-line screening, composite coatings). Their most recent project (PhytoAPP, 2021) signals a surprising pivot into biomedical nanomaterials, suggesting the team is leveraging its materials design capabilities into health applications.
NANOTECHCENTER is moving from fundamental materials physics toward application-driven research in nanoelectronics and biomedical nanomaterials, making them increasingly relevant for industry-facing consortia.
How they like to work
NANOTECHCENTER consistently participates as a partner rather than a coordinator, contributing specialist materials science expertise to larger consortia. With 58 unique partners across 29 countries from just 7 projects, they operate in broad, internationally diverse teams — mostly through MSCA-RISE mobility schemes, which emphasizes their role as a knowledge exchange node. This makes them an accessible, low-friction partner experienced in international research staff exchange.
Remarkably wide network for their size: 58 unique partners across 29 countries from only 7 projects, reflecting the large consortia typical of MSCA-RISE schemes. Their connections span most of Europe and likely extend into Asia and the Americas through RISE international mobility.
What sets them apart
As a Ukrainian SME with deep nanomaterials expertise and a track record of 7 H2020 projects, NANOTECHCENTER occupies a rare position: a small private company with research-grade capabilities in ferroelectrics, multiferroics, and memristive materials. Their combination of fundamental physics knowledge with emerging applied focus (neuromorphic computing, safe nanomanufacturing, biomedical materials) makes them versatile across multiple sectors. For consortium builders, they offer specialist materials science from an underrepresented country with proven ability to integrate into large international teams.
Highlights from their portfolio
- MELONTheir largest project (EUR 294,400) and most forward-looking — targeting memristors and multiferroic materials for neuromorphic computing, a field with strong commercial potential.
- PhytoAPPRepresents a bold cross-sector move into biomedical applications, using nanomaterial design expertise to develop inhibitors for Alzheimer's and Parkinson's diseases.
- ENGIMACore materials science project combining magnetoelectric coupling, superlattices, and multicaloric functionalities — the technical foundation that underpins their broader portfolio.